Restoration of FcRγ/Fyn signaling repairs central nervous system demyelination

Authors

  • Chika Seiwa,

    1. Department of Neuro-Glia Cell Biology, Tokyo Metropolitan Institute of Gerontology, Tokyo, Japan
    Search for more papers by this author
    • The first two authors contributed equally to this work.

  • Masahiro Yamamoto,

    1. Department of Neuro-Glia Cell Biology, Tokyo Metropolitan Institute of Gerontology, Tokyo, Japan
    2. Pharmacology Research Department, Central Research Laboratories, Tsumura and Co., Ibaraki, Japan
    3. Department of Kampo Medicine, Keio University School of Medicine, Tokyo, Japan
    Search for more papers by this author
    • The first two authors contributed equally to this work.

  • Kayoko Tanaka,

    1. Biomedical Research Center, Division of Morphological Science, Saitama Medical School, Saitama, Japan
    Search for more papers by this author
  • Masato Fukutake,

    1. Department of Neuro-Glia Cell Biology, Tokyo Metropolitan Institute of Gerontology, Tokyo, Japan
    2. Pharmacology Research Department, Central Research Laboratories, Tsumura and Co., Ibaraki, Japan
    Search for more papers by this author
  • Toshiyuki Ueki,

    1. Department of Neuro-Glia Cell Biology, Tokyo Metropolitan Institute of Gerontology, Tokyo, Japan
    2. Pharmacology Research Department, Central Research Laboratories, Tsumura and Co., Ibaraki, Japan
    Search for more papers by this author
  • Shuichi Takeda,

    1. Pharmacology Research Department, Central Research Laboratories, Tsumura and Co., Ibaraki, Japan
    Search for more papers by this author
  • Risa Sakai,

    1. Department of Neuro-Glia Cell Biology, Tokyo Metropolitan Institute of Gerontology, Tokyo, Japan
    2. Department of Kampo Medicine, Keio University School of Medicine, Tokyo, Japan
    Search for more papers by this author
  • Atsushi Ishige,

    1. Department of Kampo Medicine, Keio University School of Medicine, Tokyo, Japan
    Search for more papers by this author
  • Kenji Watanabe,

    1. Department of Kampo Medicine, Keio University School of Medicine, Tokyo, Japan
    Search for more papers by this author
  • Masumi Akita,

    1. Biomedical Research Center, Division of Morphological Science, Saitama Medical School, Saitama, Japan
    Search for more papers by this author
  • Takeshi Yagi,

    1. Laboratories for Integrated Biology, Graduate School of Frontier Biosciences, Osaka University, Osaka, Japan
    Search for more papers by this author
  • Kotaro Tanaka,

    1. Department of Neurology, Toyama University School of Medicine, Toayama, Japan
    Search for more papers by this author
  • Hiroaki Asou

    Corresponding author
    1. Department of Neuro-Glia Cell Biology, Tokyo Metropolitan Institute of Gerontology, Tokyo, Japan
    • Department of Neuro-Glia Cell Biology, Tokyo Metropolitan Institute of Gerontology, Tokyo, Japan
    Search for more papers by this author

Abstract

Disruption of myelin causes severe neurological diseases. An understanding of the mechanisms that control myelination and remyelination is needed to develop therapeutic strategies for demyelinating diseases such as multiple sclerosis (MS). Our previous finding indicating the critical involvement of the γ chain of immunogloblin Fc receptors (FcRγ) and Fyn signaling in oligodendrocyte differentiaion and myelination demands a fundamental revision of the strategies used for MS therapy, because antigen–antibody complexes in MS patients may induce the direct dysregulation of myelination process as well as the inflammatory destruction of myelin sheath. Here we show that the FcRγ/Fyn signaling cascade is critically involved in cuprizone-induced demyelination/remyelination, with no lymphocytic response. The levels of phosphorylated myelin basic proteins (p-MBPs), especially the 21.5-kDa isoform, but not the levels of total MBPs, decreased markedly during demyelination induced by aging, cuprizone treatment, and double knockout of FcRγ/Fyn genes. We also showed that the recovery from demyelination in cuprizone-treated and aged mice is achieved after administration of the herbal medicine Ninjin'yoeito, an effective therapy targeting the FcRγ/Fyn—Rho (Rac1)—MAPK (P38 MAPK)—p-MBPs signaling cascade. These results suggest that the restoration of FcRγ/Fyn signaling represents a new approach for the treatment of demyelinating diseases. © 2007 Wiley-Liss, Inc.

Ancillary